Neurology News and Research

Latest Neurology News and Research

UCI study finds new cause of cerebral microbleeds

A team of researchers including UCI project scientist Rachita Sumbria, PhD and UCI neurologist Mark J. Fisher, MD have provided, for the first time, evidence that blood deposits in the brain may not require a blood vessel tear.

25 Sep 2018

Novel drug alleviates memory deficits and neuropathology in Alzheimer's animal model

New research conducted at the Lady Davis Institute at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology in an animal model.

25 Sep 2018

Common painkiller not effective in controlling chronic pain after traumatic nerve injury

A new study out today in the Journal of Neurology finds that pregabalin is not effective in controlling the chronic pain that sometimes develops following traumatic nerve injury.

25 Sep 2018

Study: Optimizing dopaminergic treatment improves non-motor symptoms and quality of life

Non-motor symptoms are common in late-stage Parkinson's disease as the frequency and severity of most of these symptoms increase with advancing disease. Optimizing dopaminergic treatment in the most severe stages can affect non-motor symptoms and improve quality of life, report scientists in the Journal of Parkinson's Disease.

25 Sep 2018

Lung cancer patients treated with invasive surgery more likely to become chronic opioid users

Patients treated with more-invasive surgical techniques for a type of early-stage lung cancer are more likely to become chronic opioid users than patients treated with minimally invasive surgery, highlighting the need for additional research into how pain management after surgery might be a contributing factor to the opioid addiction crisis, according to a study published in JAMA Oncology in September.

24 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD dementia.

24 Sep 2018

Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization

Eisai Co., Ltd. announced that it has received approval for a partial label change for the vascular embolization device DC Bead in Japan.

24 Sep 2018

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.

24 Sep 2018

Study offers solid link between visceral organs and brain’s reward, motivation system

A novel gut-to-brain neural circuit establishes the vagus nerve as an essential component of the brain system that regulates reward and motivation, according to research conducted at the Icahn School of Medicine at Mount Sinai and published September 20 in the journal Cell.

21 Sep 2018

Dopamine neurons may involve in conditions ranging from Parkinson's disease to schizophrenia

Dopamine neurons are located in the midbrain, but their tendril-like axons can branch far into the higher cortical areas, influencing how we move and how we feel.

21 Sep 2018

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the initiation of its Phase 1 trial called INFRONT, which is evaluating AL001, the company's product candidate for the treatment of a genetically-defined sub-population of patients with frontotemporal dementia.

19 Sep 2018

Processing speed important to higher order cognitive function in multiple sclerosis patients

A recent article by Kessler Foundation researchers underscores the importance of processing speed in overall cognitive function in individuals with multiple sclerosis and their performance of everyday life activities.

19 Sep 2018

Use of transcranial electrical stimulation to bolster creativity has far-reaching implications

What is creativity, and can it be enhanced -- safely -- in a person who needs a boost of imagination? Georgetown experts debate the growing use of electrical devices that stimulate brain tissue, and conclude there is potential value in the technique. However, use of these machines also raises neuro-ethical, legal, and social issues that must now be addressed.

18 Sep 2018

Amyloid β protein makes comeback as therapeutic target for Alzheimer's disease

For many years amyloid β protein was considered to be a promising therapeutic target in Alzheimer's disease but, for a long time, research results were very disappointing.

18 Sep 2018

Study: Women exposed to trauma in their lives gave birth to underweight male infants

In the first study of its kind, researchers from the Icahn School of Medicine at Mount Sinai have found significantly lower birth weights in male infants--an average decrease of 38 grams, or approximately 1.3 ounces--born to women who had been exposed to trauma at some point in their lives and who secreted higher levels of cortisol, a hormone related to stress, in late pregnancy.

18 Sep 2018

Epidural stimulation aids in recovery of individuals with spinal cord injury

For the first time since 2009, Stefanie Putnam is able to prepare - and eat - meals for herself, put the vest on her service dog, Kaz, and drive herself to activities with her horse without losing consciousness or gasping for breath.

17 Sep 2018

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma -- an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.

14 Sep 2018

Wake Forest Baptist receives federal grants to develop new treatments for neurological diseases

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, has awarded Wake Forest Baptist Medical Center two five-year grants, each worth approximately $1.5 million, to participate in two nationwide clinical trial networks.

12 Sep 2018

Study provides evidence to prevent memory decline in older blacks with mild cognitive impairment

With nearly twice the rate of dementia as whites, blacks are at a higher risk for developing diseases like Alzheimer's, but there has been little research on how to reduce this racial health disparity.

10 Sep 2018

Neurology News and Research

Latest Neurology News and Research

UCI study finds new cause of cerebral microbleeds

Novel drug alleviates memory deficits and neuropathology in Alzheimer's animal model

Common painkiller not effective in controlling chronic pain after traumatic nerve injury

Study: Optimizing dopaminergic treatment improves non-motor symptoms and quality of life

Lung cancer patients treated with invasive surgery more likely to become chronic opioid users

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Study offers solid link between visceral organs and brain’s reward, motivation system

Dopamine neurons may involve in conditions ranging from Parkinson's disease to schizophrenia

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Processing speed important to higher order cognitive function in multiple sclerosis patients

Use of transcranial electrical stimulation to bolster creativity has far-reaching implications

Amyloid β protein makes comeback as therapeutic target for Alzheimer's disease

Study: Women exposed to trauma in their lives gave birth to underweight male infants

Epidural stimulation aids in recovery of individuals with spinal cord injury

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Wake Forest Baptist receives federal grants to develop new treatments for neurological diseases

Study provides evidence to prevent memory decline in older blacks with mild cognitive impairment

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Neurology News and Research

Latest Neurology News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in